@article{article, title = {{LBA102 THOR-2 cohort 1: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients (pts) with high-risk non鈥搈uscle-invasive bladder cancer (HR NMIBC) with select fibroblast growth factor receptor alterations (FGFRALT) who received prior bacillus calmette-gu茅rin (BCG) treatment}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/j.annonc.2023.10.108 }}, year = {{2023}}, month = {{10}}, author = {{Catto JWF and Tran B and Roupret M and Gschwend JE and Loriot Y and Nishiyama H and Palou J and Daneshmand S and Hussain SA and Cutuli HJ and Procopio G et al}}, doi = {{10.1016/j.annonc.2023.10.108}}, volume = {{34}}, journal = {{Annals of Oncology}}, pages = {{S1341-S1342}}, note = {{Accessed on 2025/05/05}}}